A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Moderna led S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.

Veronique D/Gett Images Sales for the RSV vaccine, called mRESVIA, were "negligible," the company said. Bernstein investment analyst Courtney Breen told Reuters that Moderna may have to ...

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

Images/GHI/UCG/Universal Images Group via ... amid its advantages over some of the other RSV vaccines. Moderna’s RSV shot can be stored frozen and comes in a syringe, implying faster and easy ...

Image source: Getty Images. So, let's consider ... headwinds from a midyear approval and launch." Moderna's mRESVIA joined the market after RSV vaccines from Pfizer and GSK already had established ...

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest rate outlook.

After Moderna’s development of a COVID-19 vaccine fueled a massive surge in ... (Photo by: Plexi Images/GHI/UCG/Universal Images Group via Getty Images) · UCG via Getty Images Wall Street ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...